Tandem Diabetes Care (TNDM) Cash & Current Investments (2013 - 2026)
Tandem Diabetes Care posted quarterly Cash & Current Investments of $570.3 million for Q1 2026, up 54.7% year-on-year from $368.6 million in Q1 2025, and up 94.85% on a QoQ basis from $292.7 million in Q4 2025.
Tandem Diabetes Care (TNDM) has 14 years of Cash & Current Investments data on file, last reported at $570.3 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments rose 54.7% year-over-year to $570.3 million; the trailing twelve-month figure through Mar 2026 stood at $570.3 million (up 54.7% YoY), and the FY2025 full-year result was $292.7 million, down 33.23% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $570.3 million, up from $292.7 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $635.4 million in Q1 2022 and bottomed at $292.7 million in Q4 2025.
- The 5-year median for Cash & Current Investments is $473.3 million (2024), against an average of $481.6 million.
- The widest annual swing landed in 2025, when Cash & Current Investments tumbled 33.23%; it then surged 54.7% in 2026.
- A 5-year view of Cash & Current Investments shows it stood at $616.9 million in 2022, then slipped by 24.15% to $467.9 million in 2023, then dropped by 6.32% to $438.3 million in 2024, then sank by 33.23% to $292.7 million in 2025, then soared by 94.85% to $570.3 million in 2026.
- The last three Cash & Current Investments figures came in at $570.3 million (Q1 2026), $292.7 million (Q4 2025), and $319.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 8.38 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.12 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 439.60 Mn |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn | 570.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 570.26 Mn |
| Dec 31, 2025 | 292.67 Mn |
| Sep 30, 2025 | 319.11 Mn |
| Jun 30, 2025 | 315.36 Mn |
| Mar 31, 2025 | 368.63 Mn |
| Dec 31, 2024 | 438.33 Mn |
| Sep 30, 2024 | 473.31 Mn |
| Jun 30, 2024 | 452.42 Mn |
| Mar 31, 2024 | 467.81 Mn |
| Dec 31, 2023 | 467.91 Mn |
| Sep 30, 2023 | 498.16 Mn |
| Jun 30, 2023 | 507.25 Mn |
| Mar 31, 2023 | 519.59 Mn |
| Dec 31, 2022 | 616.90 Mn |
| Sep 30, 2022 | 608.73 Mn |
| Jun 30, 2022 | 635.33 Mn |
| Mar 31, 2022 | 635.39 Mn |
| Dec 31, 2021 | 623.81 Mn |
| Sep 30, 2021 | 594.99 Mn |
| Jun 30, 2021 | 545.30 Mn |
| Mar 31, 2021 | 513.44 Mn |
| Dec 31, 2020 | 484.94 Mn |
| Sep 30, 2020 | 464.52 Mn |
| Jun 30, 2020 | 426.29 Mn |
| Mar 31, 2020 | 160.21 Mn |
| Dec 31, 2019 | 176.46 Mn |
| Sep 30, 2019 | 156.95 Mn |
| Jun 30, 2019 | 131.39 Mn |
| Mar 31, 2019 | 125.60 Mn |
| Dec 31, 2018 | 129.03 Mn |
| Sep 30, 2018 | 194.85 Mn |
| Jun 30, 2018 | 86.51 Mn |
| Mar 31, 2018 | 71.88 Mn |
| Dec 31, 2017 | 14.18 Mn |
| Sep 30, 2017 | 17.45 Mn |
| Jun 30, 2017 | 27.79 Mn |
| Mar 31, 2017 | 34.56 Mn |
| Dec 31, 2016 | 10.86 Mn |
| Sep 30, 2016 | 34.08 Mn |
| Jun 30, 2016 | 54.32 Mn |
| Mar 31, 2016 | 68.43 Mn |
| Dec 31, 2015 | 71.11 Mn |
| Sep 30, 2015 | 81.75 Mn |
| Jun 30, 2015 | 97.75 Mn |
| Mar 31, 2015 | 116.38 Mn |
| Dec 31, 2014 | 67.28 Mn |
| Sep 30, 2014 | 79.88 Mn |
| Jun 30, 2014 | 94.31 Mn |
| Mar 31, 2014 | 110.77 Mn |
| Dec 31, 2013 | 129.48 Mn |
| Sep 30, 2013 | 15.55 Mn |
| Jun 30, 2013 | 30.13 Mn |
| Mar 31, 2013 | 29.44 Mn |